RHKJF (Rhoen Klinikum AG) EPS (Diluted) : $0.73 (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Rhoen Klinikum AG EPS (Diluted)?

Rhoen Klinikum AG's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was $0.16. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.73.

Rhoen Klinikum AG's EPS (Basic) for the three months ended in Sep. 2024 was $0.16. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.73.

Rhoen Klinikum AG's EPS without NRI for the three months ended in Sep. 2024 was $0.16. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was $0.70.

During the past 12 months, Rhoen Klinikum AG's average EPS without NRIGrowth Rate was 36.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Rhoen Klinikum AG's highest 3-Year average EPS without NRI Growth Rate was 23.40% per year. The lowest was -17.10% per year. And the median was -11.10% per year.

Rhoen Klinikum AG EPS (Diluted) Historical Data

The historical data trend for Rhoen Klinikum AG's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhoen Klinikum AG EPS (Diluted) Chart

Rhoen Klinikum AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Diluted)

Get a 7-Day Free Trial

0.72

0.02

0.48

0.40

0.63

Rhoen Klinikum AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EPS (Diluted)	Get a 7-Day Free Trial															0.18	0.25	0.17	0.15	0.16

Competitive Comparison of Rhoen Klinikum AG's EPS (Diluted)

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhoen Klinikum AG's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's PE Ratio distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's PE Ratio falls into.

Rhoen Klinikum AG EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Rhoen Klinikum AG's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(42.216	-	0)	/	66.938
	=	0.63

Rhoen Klinikum AG's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(10.548	-	0)	/	65.999
	=	0.16

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.73

Rhoen Klinikum AG (OTCPK:RHKJF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Rhoen Klinikum AG EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Rhoen Klinikum AG's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhoen Klinikum AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rhoen Klinikum AG (OTCPK:RHKJF) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

0NQH:UK RHK:Germany

Address

Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616

Website

https://www.rhoen-klinikum-ag.com

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.